Dr. Miller is interested in macular degeneration, diabetic retinopathy, retinal detachment, retinal vascular occlusions, trauma, macular telangiectasia, and complex medical and surgical retinal problems. He uses the latest examination and diagnostic imaging techniques in hopes of providing earlier diagnosis and treatment. Surgically, he specializes in retinal detachment repair, including complex retinal detachments related to proliferative vitreoretinopathy or traumatic injuries, macular holes, epiretinal membranes (macular pucker), and dislocated lenses. Dr. Miller is highly regarded by patients and staff for his friendly demeanor, ease of communication, and clinical competency.
Dr. Miller maintains an active research program in addition to his strong clinical retina practice. As a clinician scientist, his work focuses both on clinical research and the basic mechanisms of retinal disease through study in the laboratory. In the Mass. Eye and Ear Angiogenesis Lab, he has explored the mechanisms of retinal toxicity of systemic medications. Ongoing work explores the pathogenesis of age-related macular degeneration, macular telangiectasia, macular hole, and drug retinal toxicities.
His clinical research includes age-related macular degeneration, traumatic macular holes, macular telangiectasia. He has particularly focused on retinal imaging devices, including Swept Source OCT (investigational). With additional advances in retinal imaging, he hopes to provide earlier detection of disease or predisposing factors, better prognostic information, and disease maintenance.
Additionally, he plays an important role training ophthalmology residents and retina fellows in the clinic and operating room as a Core Faculty Member of the Harvard Ophthalmology Residency program and the Associate Director of the Vitreoretinal Fellowship.
Age-related macular degeneration, angiogenesis, diabetic eye disease, macular holes and vitreomacular interface, ocular imaging, ocular trauma, retina research, retinal detachment
For a complete list of publications, please see his CV.
Finn AP, Eliott D, Kim LA, Husain D, Wu DM, Young LH, Kim IK, Andreoli C, Skondra D, Vavvas DG, Miller JB. Characteristics and Outcomes of Simultaneous Bilateral Rhegmatogenous Retinal Detachments. OSLI Retina. 2016 Sep 1;47(9):840-5.
Miller JB, Yonekawa Y, Eliott D, Kim IK, Kim LA, Loewenstein JI, Sobrin L, Young LH, Mukai S, and Vavvas DG. Long-term Follow-up and Outcomes in Traumatic Macular Holes. Am J Ophthalmol. 2016 Jun;166:206-207.
Miller JB, Papakostas TD, Vavvas DG. Complications of emulsified silicone oil after retinal detachment repair. Semin Ophthalmol. 2014 Sep-Nov; 29 (5-6):312-8.
Miller JB, Kim LA, Wu DM, Vavvas DG, Eliott D, Husain D. Ocriplasmin (Jetrea®) for stage 2 macular holes: early clinical results. OSLI Retina. 2014 Jul 1;45 (4):293-7.
Peacock ZS, Boulos T, Miller JB, Gardiner MF, Chuang SK, Troulis MJ. Orbital fractures and ocular injuries: Is a postoperative ophthalmology exam necessary? J Oral Maxillofac Surg. 2014 Mar 24.
Miller JB, Yonekawa Y, Eliott D, Vavvas DG. A review of traumatic macular hole: diagnosis and treatment. Int Ophthalmol Clin, 2013 Fall; 53(4): 59-67.
Yonekawa Y, Andreoli C, Miller JB, Loewenstein JI, Sobrin L, Eliott D, Vavvas DG, Miller JW, Kim IK. Conversion to aflibercept for chronic refractory or recurrent neovascular age-related macular degeneration. Am J Ophthalmol, 2013 May 10.
View a complete list of publications on pubmed.gov »
To learn more about Dr. Miller, read his "Meet a Specialist" profile.